Induction of disease also resulted in a pronounced increase in KIM-1 staining (Figure 4 , M–P and Figure 5 E), and we observed a nonsignificant trend that KIM-1 staining decreased in semaglutide-treated animals by ≈40%.
← all excerpts
Molecular Characterization of the Effect of Glucagon-Like Peptide-1 Receptor Agonist Semaglutide in the Nephrotoxic Serum Nephritis Mouse Model.
1
—
—